STOPCOVID is an extensive new cross-sector, cross-discipline, experimental medicine research programme aimed at developing and re-purposing treatments for COVID-19 patients. hrough this research, the team of 150 clinicians and scientists aim to reveal and target the mechanisms controlling the harmful lung injury, inflammation and failure of repair that occur in severe COVID-19 disease. Discoveries will be immediately fed into national and global clinical trials networks, including RECOVERY. STOPCOVID Image Publication date 28 Apr, 2020
